Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022

Cook MyoSite

Pittsburgh,  PA 
United States
  • Booth: 277

Thank you for visiting the Cook MyoSite Virtual Exhibit!

Formed in 2002, Cook MyoSite is dedicated to the development and subsequent commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of a variety of disorders. 

Autologous muscle derived cells (AMDC) is a cell therapy being clinically investigated by Cook MyoSite for female stress urinary incontinence, fecal incontinence, underactive bladder, and tongue dysphagia across more than 600 subjects. 


  • Primary Human Skeletal Muscle Cells
    Use the highest quality, most characterized primary human skeletal muscle cells (skMDC) on the market. Healthy and neuromuscular diseased cells are available....

  • Cook MyoSite offers single-donor primary human skeletal muscle cells (skMDC) characterized by age, gender, race, and BMI with optimized media (MyoTonic, CryoTonic) to make cell culture growth, differentiation, and cryopreservation as reliable as possible in your lab. We offer healthy and diseased cells from a range of donors, and we can generate gene expression profiles for each lot of cells to further characterize expression levels of myogenic gene targets.

    At Cook MyoSite, our services are backed by nearly two decades of clinical experience in muscle-related research. skMDC are isolated and processed using only the highest quality materials, and our highly experienced Laboratory Research Services team provides expert customer service and technical support to ensure that the cells perform as expected.